Obesity and gonadal function of women

Pediatric Endocrinology Reviews

Volumn 1, Issue SUPPL. 3, 2004, Pages 465-470

  Diamanti Kandarakis, Evanthia ^a   Kandarakis, Helen A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Ghrelin; Hyperandrogenism; Hyperinsulinemia; Infertility; Insulin resistance; Leptin; Obesity; PCOS

Indexed keywords

ANDROGEN; ESTROGEN; GONADOTROPIN; GROWTH HORMONE; LEPTIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN;

ADIPOSE TISSUE; ANDROGEN SYNTHESIS; AROMATIZATION; CONFERENCE PAPER; DISEASE ASSOCIATION; ENDOCRINE GLAND; FEMALE; GONAD DYSFUNCTION; GONAD FUNCTION; GONADOTROPIN RELEASE; HORMONAL REGULATION; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INSULIN RESISTANCE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; REPRODUCTION;

ANDROGENS; FEMALE; GONADAL DISORDERS; HUMANS; OBESITY; OVARY; RISK FACTORS;

EID: 13444279039     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (67)

1. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson WB. Mohammed BS Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004;350(25):2549-2557
2. Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Human Reprod Update 2003;92(4):359-372
3. Pasquali R, Cassimirri F, Vicenatti. Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome. Hum Repod 1997;12(Suppl 1):82-87
4. Cogswell ME, Perry GS, Schieve LA, Dietz WH. Obesity in women of childbearing age: risks, prevention, and treatment. Prim Care Update Ob/Gyns 2001;8:89-105
5. Grodstein F, Goldman MB, Cramer DW. Body mass and ovulatory infertility. Epidemiology 1994;5:247-250
6. Robert J. Norman, Manny Noakes, Ruijun Wu, Michael J. Davies, Lisa Moran and Jim X. Wang. Improving reproductive performance in overweight/obese women with effective weight management. Human Reproduction Update, Vol 101, No.3, pp. 267-280, 2004
7. Diamanti-Kandarakis E, Kouli CR, Bergiele T et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-4011
8. Knochenhauer ES, Key TJ, Kashar-Miller M, Waggoner W, Boots LR and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism 1998;83:3078-3082
9. Diamanti-Kundurukis E and Dunaif A. New perspectives in polycystic ovary syndrome. Trends in Endocrinology and Metabolism 1996;7:267-271
10. Ahmed M Saleh and Hala S Khalil. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2004;83:614-621
11. Nestler JE, Barlascini CO, Man DH, Stenghold KA, Plymate SR, Clore JW, Blackard WR. Suppresion of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin End Met 1989;68:1027-1032
12. Barbieri RL, Makris A, Ryan KS. Effect of insulin on steroidogenesis in cultured porcine ovarian cells. Fert Ster 1987;40:237-241
13. Poretsky L, Grigorescu F, Seibel M, Moses AC, Flier JS. Distribution and characterization of insulin and insulin-like growth factor 1 receptors in normal human ovary. J Clin Endocrinol Metab 1985; 61:728-734
14. Watson H, Willis D, Mason H et al. The effects of ovarian steroids, epidermal growth factor, insulin and insulin-like growth factor-1 on ovarian stromal growth. Proceedings of the Endocrine Society, 79th Annual Meeting, June 11-14, Minneapolis, Minnesota, Bethesda, Endocrine Society Press, 1997;p 389
15. Conley A, Bird I. The role of cytochrome P450 17α-hydroxylase and 3b-hydroxysteroid dehydrogenase in the integration of gonadal and adrenal steroidogenesis via the Δ5- and Δ4-pathways of steroidogenesis in mammals. Biol Reprod 1997;56:789
16. Dunaif A, Xia J, Book CB, Schenker E, Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 1995;96:801-810
17. Andrea Dunaif, Xinqui Wu, Anna Lee, Evanthia Diamanti-Kandarakis. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am Journ Physiol Endocrinol Metab 2001;281:E392-399
18. Miller W, Auchus R, Geller D. The regulation of 17,20 lyase activity. Steroids 1997;62:133
19. Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocrine Rev 1992;13:641-669
20. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800
21. Jalkanen J, Suikkari Am, Koistinen R, Butzow R, Ritvos O, Seppala M, Ranta T. Regulation of insulin-like growth factor-binding protein -1 production in human granulosa-luteal cells. J Clin Endocrinol Metab 1989;69:1174-1179
22. Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin like growth factor-binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992;74:1355-1360
23. Leonid Poretsky, Nicholas A. Cataldo, Zev Rosenwaks and Linda C. Giudice. The Insulin-Related Ovarian Regulatory System in Health and Disease. Endocrine Rev 1999;20(4):535-582
24. Moghetti P, Castello R, Negri C, Tosi F, Spiazzi GG, Brun E, Balducci R, Toscano V, Muggeo M. Insulin infusion amplifies 17-alpha-hydroxy-corticosteroid intermediate response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab 1996;81:881-886
25. Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, Polson DW, Reed MJ, Franks S. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf) 1990;32:213-220
26. Diamanti-Kandarakis E, Couli C, Tsianateli T, Bergiele A. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. European Journal of Endocrinology 1998;138:269-274
27. Willis D, Mason H, Gilling Smith C, Franks S. Modulation by insulin of follicle stimulating hormone and luteinizing hormone action in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab 1998;81:302-309
28. Mason HD, Willis DS, Beard RW, Winston RM, Margara R, Franks S. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and to concentrations of sex steroids in follicular fluid. J Clin Endocrinol Metab 1994;79:1355-1360
29. Franks S, Robinson S, Willis D. Nutrition, insulin and polycystic ovary syndrome. Reviews of reproduction 1996;1:47-53
30. Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-191
31. Hollmann M, Ruuebaum B, Gerhard I. Effects of weight loss on the hormonal profile in obese, infertile women. Hum Reprod 1996;11:1184-1191
32. Dickey RP, Taylor SN, Curol DN, Rye PH, Lu PY, Pyrzak R. Relationship of clomiphene dose and patient weight to successful treatment. Hum Rep 1997;12:449-453
33. Lewis CG, Warness GM, Wang XJ, Matthewa CD. Failure of body mass index or body weight to influence markedly the response of ovarian hyperstimulation in normal cycling women. Fertil Steril 1990;53:1097-9
34. Norman RJ, Clark AM. Obesity and reproductive disorders; a review. Reprod Fertil Dev 1998;10:55-63
35. P Kokkoris, F Xavier, Pi-Sunyer. Obesity and endocrine disease. Endocrinol Metabol Clin N Am 2003;(32):895-914
36. Kalro PS, Kalro SP, Krulich L, Fawcett CP, McCann SM. Involvement of norepinephrine in transmission of the stimulatory influence of progesterone on gonadotrophin release. Endocrinology 1972;90;1168-1176
37. Kalra PS, Kalra SP. Opioid adrenergic steroid connection in regulation of luteinizing hormone secretion in the rat. Neuroendocrinology 1984;38:418-426
38. Kalra SP, Clark JT, Sahu A. Hypothalamic NPY: A local circuit in the control of reproduction and behavior. In Mutt, V ed, Neuropeptide Y. New York:raven Press 1989;229-241
39. Pasquali R, Cantobelli S, Casimirri F, Bortoluzzi L, Boschi S, Capelli M, Barbar L. The role of opioid peptides in the development of hyperinsulinemia in obese women with abdominal body fat distribution. Metabolism 1992;41:763-767
40. Feldman M, Kiser RS, Unger RH, Li CH. Endorfine and the endocrine pancreas Studies in healthy and diabetic human being. NEJM 1983;308:349-353
41. Mantzoros XS, Dunaif A, Flier JS. Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:1687-1691
42. Wautes MRC, Van Goal L. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endo 2000;143:293-311
43. Hileman AM, Pierroz DD, Flier JS. Leptin, Nutrition, and Reproduction: Timing is everything. J Clin Endocrinol Metab 2000;85(2):804-807
44. Barash IA, Cheung CC, Weigle DS, Ren H, Kabigting EB, Kuijper JL, Clifton DK, Steiner RA. Leptin is a metabolic signal to the reproductive system. Endocrinology 1996;137:3144-3147
45. Manzoros C. Role of leptin in reproduction. Ann NY Acad Sci 2000;900:174-183
46. Bray G and York D. Leptin and Clinical Medicine. A new piece in the puzzle of obesity. JCEM 1997;82:2771-2776
47. Vincenatti V, Gambineri F, Calzoni F, Cassimirri F, Macor C, Vettor R, Pasquali R. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels. Metabolism 1998;47(8):988-992
48. Schwartz MW, Baskin DY, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte DJr, Woods SC, Seely RJ, Weigle DS. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996;45:513-535
49. Branowska B, Waslewska-Dziubinska E, Radzikowska M, et al. NPY, galanin and leptin release in women with obesity and in women with anorexia nervosa. Meta Clin Exp 1997;46:1394-1389
50. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986;7:1189-1192
51. Bauer-Dantoin AC, McDonald JK, Levine JE. Neuropeptide Y potentiates luteinizing hormone (LH)-releasing hormone induced LH secretion only under conditions leading to preovulatory LH surges. Endocrinology 1992;31:2946-2952
52. Zarjevski N, Cusin I, Vettor R, Rohner-Jaenrenaud B. Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993;133:1753-1758
53. Rossmanith WG, Marks DL, Clifton DK, Steiner RA. Induction of galanin expression in gonadotrophin releasing hormone neurons with puberty in the rat. Endocrinology 1994;135:140-148
54. Lopez FJ, Meade EH Jr, Negro-Vilar A. endogenous galanin modulates the gonadotrophin and prolactin proestrous surges in the rat. Endocrinology 1993;132:795-800
55. Steppan CM, Laxzar MA. Resistin and obesity-associated insulin resistance. Review Trends Endocrinol Metab 2002;13(1):18-23
56. Peraldi P, Spiegelman B. TNF-α and insulin resistance: summary and future prospects. Mol Cell Biochem 1998;182:169-175
57. Adashi EY. The potential relevance of cytokines to ovarian physiology: the emerging role of resident ovarian cells of the white blood cell series. Endocr Rev 1990;11:454-464
58. Cianci A, Calogero AE, Palumbo MA, Burrello N, Ciotta L, Palumbo G, Bernardini R. Relationship between tumor necrosis factor and sex steroid concentrations in the follicular fluid of women with immunological infertility. Human Reproduction 1996;11(2):265-268
59. Arvat EI, Di Vito L, Broglio F, et al. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000;23:493-495
60. Kojima M, Hosoda H, Date Y, Najazato M, Matsuo H, Kangawa K. Gherlin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660
61. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407:908-913
62. Ariyashu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753-4758
63. Shiiya T, Nakazato M, Minuza M, et al. Plasma ghrelin levels in lean and obese human and the effect of glucose on ghrelin secretion. J Clin ENdocrinol Metab 2002;87:240-244
64. Pagotto U, Gambineri A, Vicennati V, Heiman ML, Tschop M, Pasquali R. Ghrelin, obesity and the polycystic ovary syndrome: correlations with insulin resistance and androgen levels. J Clin ENdocrinol Metab 2002;87:5625-5629
65. Tena-Sempere M, Barreio ML, Gonzalez LC, et al. Novel expression and functional role of ghrelin in rat testis. Endocrinology 2002;143:717-725
66. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407:908-913
67. Hippocrates. Airs, Waters, Places (an essay on the influence of climate, water supply and situation on health). In Hippocratic Writings; Section on Medicineparas 20-21, 1978 , reprinted 1983 pp164-165 translated by J Chadwick and WN Mann. Penguin Classics, London